Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD)

NCT04186403 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

201

Enrollment

INDUSTRY

Sponsor class

Conditions

Borderline Personality Disorder

Interventions

DRUG: Brexpiprazole

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.